68Ga-PSMA PET/CT in Preoperative Staging of Intermediate and High Risk Prostate Cancer Patients

被引:0
|
作者
Schiller, C. [1 ]
Beheshti, M. [1 ]
Geinitz, H. [2 ]
Aschacher, B. [2 ]
Moinfar, F. [3 ]
Broinger, G. [3 ]
Pallwein-Prettner, L. [4 ]
Loidl, W. [5 ]
Langsteger, W. [1 ]
机构
[1] St Vincents Hosp, PET CT Ctr Linz, Linz, Austria
[2] St Vincents Hosp, Dept Radiat Oncol, Linz, Austria
[3] St Vincents Hosp, Dept Clin Pathol, Linz, Austria
[4] St Vincents Hosp, Dept Radiol, Linz, Austria
[5] St Vincents Hosp, Prostate Canc Ctr Linz, Dept Urol, Linz, Austria
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP555
引用
收藏
页码:S167 / S167
页数:1
相关论文
共 50 条
  • [41] Combined Intravenous Urogram and 68Ga-PSMA PET/CT for Improved Staging and Restaging of Prostate Cancer
    McBean, Rhiannon
    Kumari, Anisa
    McEwan, Louise
    Walters, James
    Wong, David
    JOURNAL OF CLINICAL IMAGING SCIENCE, 2020, 10
  • [42] Advantages of 68Ga-PSMA I&T PET/CT in primary staging of prostate cancer
    Cytawa, W.
    Bandurski, T.
    Tran-Gia, J.
    Schirbel, A.
    Fukushima, K.
    Wester, H.
    Lass, P.
    Brockhuis, B.
    Polom, W.
    Buck, A. K.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S449 - S449
  • [43] THE ROLE OF 68GA-PSMA PET-CT IN INITIAL STAGING OF TREATMENT-NAIVE HIGH RISK PROSTATE CANCER.
    Pooli, Aydin
    Sadun, Taylor Y.
    Johnson, David C.
    Lebacle, Cedric
    Fendler, Wolfgang P.
    Eiber, Matthias
    Czernin, Johannes
    Calais, Jeremie
    Reiter, Robert E.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E742 - E742
  • [44] 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
    Klingenberg, Soren
    Jochumsen, Mads R.
    Ulhoi, Benedicte P.
    Fredsoe, Jacob
    Sorensen, Karina D.
    Borre, Michael
    Bouchelouche, Kirsten
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 214 - 220
  • [45] Use of 68Ga-PSMA-HBED-CC (68Ga-PSMA-11) PET/CT At Initial Staging For Intermediate And High-Risk Prostate Cancer
    dos Santos, G.
    Banchero, A.
    Leiva, J.
    Trindade, V.
    Savio, E.
    Vilche, S.
    Perez, L.
    Gambini, J.
    Duarte, P.
    Alonso, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S538 - S538
  • [46] 68Ga-PSMA PET/CT in Staging and Restaging of prostate Cancer Patients: Comparative Study with 18F-Choline PET/CT
    Langsteger, W.
    Imamovic, L.
    Geinitz, H.
    Schiller, C.
    Moinfar, F.
    Rezaee, A.
    Pallwein-Prettner, L.
    Loidl, W.
    Beheshti, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S166 - S166
  • [47] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 130 : 1 - 12
  • [48] LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT
    Chan, Mico
    Hsiao, Edward
    Turner, Jennifer
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 193 - 194
  • [49] Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
    Thomas Pyka
    Shozo Okamoto
    Marielena Dahlbender
    Robert Tauber
    Margitta Retz
    Matthias Heck
    Nagara Tamaki
    Markus Schwaiger
    Tobias Maurer
    Matthias Eiber
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2114 - 2121
  • [50] Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
    Pyka, Thomas
    Okamoto, Shozo
    Dahlbender, Marielena
    Tauber, Robert
    Retz, Margitta
    Heck, Matthias
    Tamaki, Nagara
    Schwaiger, Markus
    Maurer, Tobias
    Eiber, Matthias
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2114 - 2121